- Home
- ALLR vs FLGC Comparison
ALLR vs FLGC Comparison
Compare ALLR & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- FLGC
- Stock Information
- Founded
- ALLR 2004
- FLGC 2019
- Country
- ALLR United States
- FLGC United States
- Employees
- ALLR N/A
- FLGC N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- ALLR Health Care
- FLGC Health Care
- Exchange
- ALLR Nasdaq
- FLGC Nasdaq
- Market Cap
- ALLR 15.8M
- FLGC 13.5M
- IPO Year
- ALLR N/A
- FLGC 2021
- Fundamental
- Price
- ALLR $1.73
- FLGC $18.64
- Analyst Decision
- ALLR Strong Buy
- FLGC Strong Buy
- Analyst Count
- ALLR 1
- FLGC 1
- Target Price
- ALLR $9.25
- FLGC $156.00
- AVG Volume (30 Days)
- ALLR 641.5K
- FLGC 106.5K
- Earning Date
- ALLR 11-13-2025
- FLGC 11-12-2025
- Dividend Yield
- ALLR N/A
- FLGC N/A
- EPS Growth
- ALLR N/A
- FLGC N/A
- EPS
- ALLR N/A
- FLGC N/A
- Revenue
- ALLR N/A
- FLGC $52,373,000.00
- Revenue This Year
- ALLR N/A
- FLGC N/A
- Revenue Next Year
- ALLR N/A
- FLGC $10.22
- P/E Ratio
- ALLR N/A
- FLGC N/A
- Revenue Growth
- ALLR N/A
- FLGC N/A
- 52 Week Low
- ALLR $0.61
- FLGC $15.15
- 52 Week High
- ALLR $2.35
- FLGC $82.29
- Technical
- Relative Strength Index (RSI)
- ALLR 58.71
- FLGC 45.47
- Support Level
- ALLR $1.54
- FLGC $17.52
- Resistance Level
- ALLR $1.65
- FLGC $20.18
- Average True Range (ATR)
- ALLR 0.13
- FLGC 4.33
- MACD
- ALLR -0.01
- FLGC -1.14
- Stochastic Oscillator
- ALLR 72.97
- FLGC 5.95
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.